Trial · NCT01447446
Participant flow18
How many started, completed or left each group, period by period.
1 to 18 of 18
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Dual Therapy: Peg-IFN Alfa-2a + Ribavirin | 2,312 | |
| Overall Study | STARTED | Dual Therapy: Peg-IFN Alfa-2b + Ribavirin | 496 | |
| Overall Study | STARTED | Triple Therapy: Boceprevir + Peg-IFN Alfa-2a + Ribavirin | 292 | |
| Overall Study | STARTED | Triple Therapy: Boceprevir + Peg-IFN Alfa-2b + Ribavirin | 93 | |
| Overall Study | STARTED | Triple Therapy: Telaprevir + Peg-IFN Alfa-2a + Ribavirin | 821 | |
| Overall Study | STARTED | Triple Therapy: Telaprevir + Peg-IFN Alfa-2b + Ribavirin | 86 | |
| Overall Study | COMPLETED | Dual Therapy: Peg-IFN Alfa-2a + Ribavirin | 1,590 | |
| Overall Study | COMPLETED | Dual Therapy: Peg-IFN Alfa-2b + Ribavirin | 331 | |
| Overall Study | COMPLETED | Triple Therapy: Boceprevir + Peg-IFN Alfa-2a + Ribavirin | 192 | |
| Overall Study | COMPLETED | Triple Therapy: Boceprevir + Peg-IFN Alfa-2b + Ribavirin | 60 | |
| Overall Study | COMPLETED | Triple Therapy: Telaprevir + Peg-IFN Alfa-2a + Ribavirin | 610 | |
| Overall Study | COMPLETED | Triple Therapy: Telaprevir + Peg-IFN Alfa-2b + Ribavirin | 54 | |
| Overall Study | NOT COMPLETED | Dual Therapy: Peg-IFN Alfa-2a + Ribavirin | 722 | |
| Overall Study | NOT COMPLETED | Dual Therapy: Peg-IFN Alfa-2b + Ribavirin | 165 | |
| Overall Study | NOT COMPLETED | Triple Therapy: Boceprevir + Peg-IFN Alfa-2a + Ribavirin | 100 | |
| Overall Study | NOT COMPLETED | Triple Therapy: Boceprevir + Peg-IFN Alfa-2b + Ribavirin | 33 | |
| Overall Study | NOT COMPLETED | Triple Therapy: Telaprevir + Peg-IFN Alfa-2a + Ribavirin | 211 | |
| Overall Study | NOT COMPLETED | Triple Therapy: Telaprevir + Peg-IFN Alfa-2b + Ribavirin | 32 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01447446/flow